BPC-157 XENO LABS USA

Body Protect Compound for Accelerated Healing & Tissue Repair

BPC-157 (Body Protect Compound) is an entirely natural gastric juice peptide, derived from a protein found in your own stomach. It is highly stable and resistant to human gastric juice, giving it the classification of a “stable gastric pentadecapeptide.” Although the body produces BPC-157 in small amounts to protect and heal the intestines, the super-concentrated version exhibits extremely high biological healing activity wherever it is applied.

The full fifteen amino acid sequence is notably complex: L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylgsil-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leucine; glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglisilsil-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglisil-L-leusil-L-valine.

Remarkable Healing & Anti-Inflammatory Benefits (Pre-Clinical Research)

Since 1991, extensive research (primarily in vitro and in vivo rodent studies) has demonstrated BPC-157’s wide range of therapeutic effects:

• Musculoskeletal Repair: Promotes accelerated healing of tendons, ligaments, muscles, and bones. Demonstrated effective in rodent models with Achilles tendon tears and damaged medial collateral ligaments, promoting tendon growth and tendon-to-bone healing.

• Gastrointestinal Protection: Heals damage from Inflammatory Bowel Disease (IBD) within days after oral application in rodent models. It has ulcer-preventive effects and accelerates the return of intestinal anastomosis in severely impaired conditions.

• Painkiller Reversal: Eliminates the harmful effects of painkillers on the gastrointestinal tract.

• Counteracts Corticosteroid Damage: Reversed systemic corticosteroid-damaged muscle healing in rodents when administered orally.

• Angiogenic Effects: Accelerates wound healing through interaction with the Nitric Oxide (NO) system, promoting the preservation of endothelial tissue and the formation of new blood vessels (“angiogenic” effect).

Technical Specifications and Dosing

Dosage (Anecdotal Reports)

There is no common scientific consensus on human dosage, but systematic research in animals suggests effectiveness between 1–10 mcg per kilogram of body weight once a day. Anecdotal experiences suggest successful doses range from 200 mcg to 800 mcg anywhere, with some users reporting success at 250–350 mcg twice a day (total daily dose 500–700 mcg).

Important Regulatory and Legal Disclaimer

• FDA Status: BPC-157 is not approved by the FDA as a drug for human use.

• Patent Status: Because it is an entirely natural gastric juice peptide, it cannot be patented. Major pharmaceutical companies cannot market this substance, which is why your doctor, surgeon, or gastroenterologist has not informed you about it.

• WADA/USADA Status: The use of BPC-157 in sports is subject to strict regulation. While some “peptide hormones, growth factors, related substances, and mimetics” are prohibited, BPC-157 is not currently listed as one of these illegal compounds. (Note: This status is constantly reviewed by organizations like WADA and may change.)

• Human Safety Data: There have been no long-term human studies to date, and 90% of the research originated from the same clinical study.